Latest Administration News

AVITA Medical reported a 13% revenue decline in Q3 2025 but improved cash efficiency and secured Medicare payment confirmations for RECELL®, positioning for growth in 2026.

Haranga Resources has launched the second phase of a 3,000-metre Aircore drilling campaign at its Ibel South Gold Project in Senegal, following promising high-grade gold results from its maiden program. The new drilling aims to confirm and expand mineralised zones ahead of a deeper 2026 drilling campaign.

Finaccess Restauración, S.L. has secured acceptances exceeding 90% in its takeover bid for Restaurant Brands New Zealand, setting the stage for compulsory acquisition of remaining shares and imminent delisting.

Javelin Minerals has initiated a significant capital consolidation, reducing its share count by a factor of 31, and is introducing a facility to help small shareholders sell untradeable parcels post-consolidation.

Immuron Limited has secured FDA approval for its IMM-529 Investigational New Drug application, clearing the way for a Phase 2 clinical trial targeting Clostridioides difficile infection. This milestone marks a significant step forward for a novel oral antibody therapy addressing a critical infectious disease with high recurrence rates.

Mesoblast is set to meet the FDA in December to discuss compelling Phase 3 data showing its cell therapy rexlemestrocel-L may significantly reduce opioid use in chronic low back pain patients. This meeting could mark a pivotal step in addressing the US opioid crisis through innovative regenerative medicine.

Imagion Biosystems reports encouraging findings from its Wayne State University collaboration, supporting a lower dose for its MagSense® HER2 imaging agent ahead of a planned FDA IND submission in Q4 2025.

TrivarX Limited has exercised its option to acquire the innovative Stabl-Im brain imaging technology, aiming to revolutionize early detection of brain tumours pending shareholder approval.

Medibank is set to acquire Better Medical, a network of 61 GP clinics across four states, for approximately $159 million, enhancing its primary care footprint and preventive health initiatives.

Altech Batteries confirms the strategic importance of its AMPower Agreement, enabling immediate sales and cash flow, while detailing a recent $6 million capital raising and addressing trading compliance issues.

Almonty Industries reported a strong net income in Q3 2025, driven by a significant non-cash warrant gain, while advancing the ramp-up of its flagship Sangdong Mine amid rising tungsten demand.

LCL Resources Limited faces suspension from ASX trading due to failure to lodge a required periodic report on time, raising questions about the company’s compliance and operational transparency.